Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2026 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de serviceAcceptable Use
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to Reports
Biotech

Caris Life Sciences

Caris Life Sciences raises $168M Growth at $1.9B valuation

Irving, TXOctober 6, 20251 min read
Total Raised
$168M
Valuation
$1.9B
Latest Round
Growth
Employees
1000+

Caris Life Sciences: Growth Funding Round

Caris Life Sciences has successfully raised $168M in Growth funding, reaching a valuation of $1.9B.

Company Overview

Molecular profiling and AI/ML for precision medicine development

Funding Details

The Growth round was led by Braidwell.

Company Information

  • Headquarters: Irving, TX
  • Founded: 2018
  • Employees: 1000+
  • Category: Biotech

Investment

Caris Life Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Braidwell: Verified investor in Growth

Company Info

Headquarters
Irving, TX
Founded
2018
Team Size
1000+
Last Round
$168M(Oct 2025)

Investors (1)

B
BraidwellLead
Lead Investor
Verified investor in Growth

Topics

verified(3079)real-funding(3079)caris-life-sciencesbiotechgrowthirving

Share

Related Reports

Biotech
AusperBio

AusperBio Raises $73M Series B

Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials

David Chen
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics

Orna Therapeutics Raises $251M Series B

Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases

Emma Rodriguez
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics

Forge Biologics Raises $120M Series C

Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines

Sarah Kim
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free